| dc.contributor.author | Kumar, Gautam | |
| dc.date.accessioned | 2025-03-15T05:16:24Z | |
| dc.date.available | 2025-03-15T05:16:24Z | |
| dc.date.issued | 2018-04 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0223523418301016 | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18371 | |
| dc.description.abstract | A series of pyrazole-pyrazoline substituted with benzenesulfonamide were synthesized and evaluated for their antimalarial activity in vitro and in vivo. The compounds were active against both chloroquine (CQ) sensitive (3D7) and CQ resistant (RKL-9) strains of Plasmodium falciparum. Seven compounds (7e, 7i, 7j, 7l, 7m, 7o and 7p) exhibiting EC50 less than 2 μM. A mechanistic study of compound 7o revealed that these compound act through the inhibition of β-hematin. The study indicated that these compounds can serve as lead compounds for further development of potent antimalarial drugs. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Plasmodium falciparum | en_US |
| dc.subject | Antimalarial | en_US |
| dc.subject | Heme binding | en_US |
| dc.subject | Pyrazoline | en_US |
| dc.title | Pyrazole-pyrazoline as promising novel antimalarial agents: a mechanistic study | en_US |
| dc.type | Article | en_US |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||